2 hrs ago | foxnews.com
I have knocked down two of the four chemotherapy treatments I need to complete in the month of May. Today will be chemo #3, and after next week (chemo #4), we will scan my liver and see where we stand
Read more...
Noreen Fraser Noreen chemo poison cancer pick Fraser 12-week morphine metastatic chemos January-February-March chemotherapy pain liver tumor STAND UP
4 hrs ago | premiumpresse.de
Woburn, Massachusetts And Tokyo (otsPRNewswire) - ArQule, Inc. and Daiichi Sankyo, Co., Ltd. (TSE 4568) todayannounced that an oral presentation at the Annual Meeting of theAmerican Society of Clinical Oncology (ASCO) will...
Read more...
tivantinib ArQule Sankyo Poster Daiichi ARQ c-MET HCC trial Phase clinical
5 hrs ago | finance.yahoo.com
TASER International (TASR) received an order from the Ohio State Highway Patrol Academy for 485 TASER X26 ECDs. Also, co received a second order from from the Austin Police Department for 100 TASER X26 ECDs with extended...
Read more...
rev Estimate Consensus IQ mln Q1 FY13 Co bln comps Capital EPS in-line Q2 guidance GasLog ScreenCell $0.03 $0.05 beat CoreValve
11 hrs ago | finanznachrichten.de
SILENCE THERAPEUTICS PLC - New data from Phase I trial with Atu027 FOR IMMEDIATE RELEASE Atu027, a First in Class RNAi Therapy, Demonstrates Potential Antitumour Activity in Cancer Patients and Possible Biomarker Identified...
Read more...
Atu027 siRNA Phase silence RNAi therapeutics plc PKN3
11 hrs ago | euronext.com
Regulatory News: Transgene (Paris:TNG) (Euronext Paris: FR0005175080) today announces that four separate abstracts relating to clinical studies of the therapeutic cancer vaccine TG4010 and the oncolytic virus JX594/TG6006 have...
Read more...
TG4010 Transgene TG6006 JX594 cancer JX-594 phase
19 hrs ago | finanznachrichten.de
Ten Oral Presentations Underscore Breadth and Diversity of Company's Oncology Portfolio New Data on YERVOY® (ipilimumab) and the Investigational Compounds Anti-PD-1 (BMS-936558) and Elotuzumab Reinforce Company's Leadership in...
Read more...
YERVOY Bristol-Myers Squibb immune-mediated metastatic melanoma ERBITUX Oncology elotuzumab SPRYCEL Presented treatment Data CML cancer patient BMS-936558 Portfolio endocrinopathy investigational Phase ASCO study reaction myeloma
21 hrs ago | springerlink.com
Conclusion The preliminary experience suggests that glue embolization may be an effective and safe therapy in the management of severe APS accompanied by HCC and also improve patient survival. Content Type Journal...
Read more...
Hai-Bin Shi Transarterial APS shunt Emb non-Emb embolization HCC severe hepatofugal chemoperfusion patient glue cyanoacrylate survival
May 16, 2012 | cancer.gov
Experimental Antibody for Treatment-Resistant Liver Cancer Name of the Trial TRC 105 for Liver Cancer that Has Not Responded to Sorafenib (NCI-11-C-0181). See the protocol summary . Principal Investigator Dr. Tim Greten, NCI...
Read more...
Treatment-Resistant liver cancer hepatocellular experimental carcinoma trial NCI-11-C-0181 patient
May 16, 2012 | finanznachrichten.de
WOONSOCKET, R.I., May 16, 2012 /PRNewswire/ --MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce representatives from the Company will present preclinical research findings for MCT-465 and MCT-485 at...
Read more...
MultiCell MCT-465 MCT-485 immune cell cancer tumor TLR3 MDA-5
May 16, 2012 | newstarget.com
The cancer industry is closing in on baking soda and beginning to do research in earnest about sodium bicarbonate and how it is a primary tool in the treatment of fungus. Cancer is a fungus, can be caused by a fungus, or is...
Read more...
fungus cancer fungal infection Sircus spp soda tissue baking aflatoxin sodium bicarbonate patient tumor
May 16, 2012 | chemie.de
The purpose of this study was to evaluate the antioxidant nature of tea polyphenol on S180 cells induced liver cancer in mice. In the present study, hepatocellular carcinoma was induced by tumor transplantation of liver in...
Read more...
S180 tea polyphenol cell serum antioxidant effect hepatocellular induce liver Qi-Bo aminotransfere Bo-Kang MDA
May 16, 2012 | nucleonica.net
Sirtex Medical Limited (Sirtex), a biotechnology and medical device company is engaged in the developing, manufacturing and marketing of selective internal radiation therapies (SIRT) in the area of liver cancer. Its principal...
Read more...
All similar articles: 443 >>
Sirtex GlobalData SRX analysis key financial profile swot Medical Pty
May 15, 2012 | karger.com
Woubet T. Kassahuna, Bianca Guenla, Fritz R. Ungemachb, Sven Jonasa, Getu Abrahamb aDepartment of Surgery II, Faculty of Medicine, and bInstitute of Pharmacology, Pharmacy and Toxicology, University of Leipzig, Leipzig, Germany...
Read more...
β2 HCC Hepatocellular AR β expression receptor Gsα postreceptor density liver ARs protein membrane
May 15, 2012 | hotstockmarket.com
› The Alert Competition Room - rules on first post I've been trading with them for two weeks and everything has gone smoothly. Edit: Dec 5 On Dec 2 they experienced system problems and I have been unable to place any trades....
Read more...
liver MultiCell Alert Competition afford Room 7935528 Newmin Technologies stem cell disease risk UNDT location post chart never lose rule USPTO
May 15, 2012 | fortmilltimes.com
Galectin Therapeutics (NASDAQ: GALT) (“the Company”), the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin proteins for the therapy of liver fibrosis and cancer, today announced that the first...
Read more...
Galectin GM-CT-01 patient Therapeutics metastatic trial initiation peptide therapy universitaires Cliniques Saint-Luc vaccination carbohydrate-based peri-tumoral melanoma NA17.A2 vaccine Baurain combination novel
May 15, 2012 | premiumpresse.de
LAWRENCEVILLE, NJ -- (Marketwire) -- 051512 -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced financial results for the first quarter ended March 31, 2012 and provided a...
Read more...
ThermoDoxreg Celsion HEAT Study Companys liver Phase RFA cancer
May 15, 2012 | intute.ac.uk
Athena P. Kourtis, M.D., Ph.D., M.P.H., Marc Bulterys, M.D., Ph.D., Dale J. Hu, M.D., M.P.H., and Denise J. Jamieson, M.D., M.P.H. Human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV) exact a high toll...
Read more...
Athena P. Kourtis HBV HIV hepatitis coinfection coinfected perinatal HIV-infected
May 15, 2012 | investir.fr
DGAP-News: 4SC AG / Key word(s): Miscellaneous Press Release 4SC AG: 4SC's partner Yakult Honsha starts clinical development with cancer compound resminostat in Japan Press Release 4SC's partner Yakult Honsha starts clinical...
Read more...
4SC resminostat Yakult Honsha HCC AG DE0005753818 cancer clinical
May 14, 2012 | eurekalert.org
A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers,...
Read more...
bile duct cancer Duke-NUS Singapore gene NCCS Cholangiocarcinoma Thailand Kaen Khon liver mutation Research scientist Andel Teh discovery breakthrough
May 14, 2012 | euronext.com
Regulatory News: BioAlliance Pharma SA (Euronext Paris:BIO), a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag®...
Read more...
BioAlliance Livatag ReLive Pharma phase clinical trial III SA
May 14, 2012 | finanznachrichten.de
Issue Date: May 14, 2012 Media Alert Media Contacts: LILLY ONCOLOGY TO DISCLOSE NEW PIPELINE DATA AT ASCO 2012 Updates on Three of Six Ongoing Phase III Ramucirumab Trialsto Be Presented INDIANAPOLIS, May 14, 2012 - Eli Lilly...
Read more...
Lilly ramucirumab ASCO LY900009 LY2228820 oral IMC-1121B inhibitor pipeline first-in-human cancer patient Phase poster III abstract dimesylate
May 13, 2012 | gannett-tv.com
HOUSTON - Mother's Day celebrates that special bond between a mother and her child. Part of that bond is what is known as a mother's intuition, and one mom is grateful that she trusted hers. She will be celebrating her first...
Read more...
Ava tumor Browning mother baby save chemo intuition life birth pediatric hepatoblastoma blastoma newborn liver child
May 13, 2012 | hamptonroads.com
greenbrier Damion Kelly still has the scar. The 5-year-old from Virginia Beach was 7 months old when he was diagnosed with neuroblastoma and had to have a malignant tumor removed from nerve tissue in the right side of his back....
Read more...
Lydia Wheeler Chesapeake Relay cancer Klatt Life Carlile Hastings Damion Linda Curt
May 12, 2012 | edurneweb.com
At the same time, the enumerated below concepts are very important both for communities: always make sure appropriate all-around routine and in addition sanitation, a good availabilit of good water supply, and therefore highly...
Read more...
enumerated intestinal furazolidone concept fitflop cholera malabsorption biliary tract antibiotic tetracycline colic treatment below insufficiency sickness.Pancreatic syndrome.Bile sameCheap syndromeMaldigestion the.delaware sprue.Alternative Youths.Commercial cirrhosis colitis care.Lee Heels
May 10, 2012 | docstoc.com
International Journals Call for paper, http://www.iiste.org Journal of Biology, Agriculture and Healthcare www.iiste.org Hepatoid Adenocarcinoma of the Stomach – a rare histology of Gastric Adenocarcinoma in an adolescent: a...
Read more...
Hepatoid adenocarcinoma stomach carcinoma www.iiste.org hepatocellular
May 10, 2012 | catholic.org
More efforts are needed to recognize cancer as a communicable disease One in six cancers, or two million cases a year globally are caused by largely treatable or preventable infections, a new study suggests. According to the...
Read more...
cancer infection infection-related U.K. HPV preventable case vaccination pylori suggest study liver vaccine
May 10, 2012 | investir.fr
DGAP-News: 4SC AG / Key word(s): Quarter Results/Miscellaneous Press Release 4SC AG: 4SC Announces Financial Results for the First Quarter of 2012 Press Release 4SC Announces Financial Results for the First Quarter of 2012...
Read more...
4SC resminostat AG 2012 DGAP-News vidofludimus
May 9, 2012 | comparenetworks.com
Researchers at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a miniaturized biochip for investigating the effect of drugs on...
Read more...
CSCs IBN Droplet cell Array cancer drug tumor stem
May 9, 2012 | jimbocyberdoc.wordpress.com
This morning, during the ward round, the daughter-in-law of a man repeated implored me to not tell the latter that he has hepatocellular carcinoma which has spread to his spine. He was admitted for progressively enlarging...
Read more...
DIL diagnosis patient dark doctor conspiracy daughter-in-law father-in-law prognosis abdomen pussy-footed faith-healer liver condition fluid cure terminal
May 9, 2012 | cbc.ca
Death rates for the four major cancers — lung, colorectal, breast and prostate — are declining, thanks to falling smoking rates and increases in screening and treatment, the Canadian Cancer Society says.
Read more...
All similar articles: 140 >>
cancer death rate decline colorectal Canadian incidence smoking lung thyroid breast liver
